These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 24792457

  • 1. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing.
    Maass AH, Van Gelder IC.
    Europace; 2014 Jul; 16(7):1032. PubMed ID: 24792457
    [No Abstract] [Full Text] [Related]

  • 2. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J, Bader YH, Maron MS, Rowin EJ, Link MS.
    J Am Heart Assoc; 2016 Feb 12; 5(2):. PubMed ID: 26873684
    [Abstract] [Full Text] [Related]

  • 3. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.
    Volosin KJ, Exner DV, Wathen MS, Sherfesee L, Scinicariello AP, Gillberg JM.
    J Cardiovasc Electrophysiol; 2011 Mar 12; 22(3):280-9. PubMed ID: 20958831
    [Abstract] [Full Text] [Related]

  • 4. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P, Adduci C, Palano F, Semprini L, Serdoz A, Montesanti D, Santini D, Musumeci B, Salvati A, Volpe M, Autore C.
    J Cardiovasc Electrophysiol; 2015 Aug 12; 26(8):893-899. PubMed ID: 25996259
    [Abstract] [Full Text] [Related]

  • 5. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA, Deeprasertkul P, Nannapaneni N, Carayannopoulos GN.
    J Cardiovasc Electrophysiol; 2015 Feb 12; 26(2):228-9. PubMed ID: 25354719
    [No Abstract] [Full Text] [Related]

  • 6. Recent developments in the subcutaneous ICD.
    Willcox ME, Prutkin JM, Bardy GH.
    Trends Cardiovasc Med; 2016 Aug 12; 26(6):526-35. PubMed ID: 27079889
    [Abstract] [Full Text] [Related]

  • 7. Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?
    Gerstenfeld EP.
    J Cardiovasc Electrophysiol; 2010 Sep 12; 21(9):1000-1. PubMed ID: 20487115
    [No Abstract] [Full Text] [Related]

  • 8. Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy.
    Furushima H, Chinushi M, Iijima K, Sanada A, Izumi D, Hosaka Y, Aizawa Y.
    J Cardiovasc Electrophysiol; 2010 Sep 12; 21(9):991-9. PubMed ID: 20487113
    [Abstract] [Full Text] [Related]

  • 9. Ventricular fibrillation triggered by a pacemaker-mediated tachycardia protection algorithm.
    Galand V, Behar N, Martins RP.
    Europace; 2017 Aug 01; 19(8):1342. PubMed ID: 28444182
    [No Abstract] [Full Text] [Related]

  • 10. Inappropriate shock because of triple counting in a patient with a subcutaneous implantable cardioverter defibrillator corrected by initiation of dual site left ventricular pacing.
    van Gelder BM, Bracke FA, Simmers T.
    Circ Arrhythm Electrophysiol; 2015 Feb 01; 8(1):239-40. PubMed ID: 25691559
    [No Abstract] [Full Text] [Related]

  • 11. Prolonged sustained ventricular fibrillation in a patient with dextrocardia and a left ventricular assist device.
    Bolzan B, Morani G, Tomei R, Tomasi L, Borio G, Ribichini FL.
    J Cardiovasc Med (Hagerstown); 2019 Oct 01; 20(10):721-724. PubMed ID: 31389822
    [No Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.
    Buber J, Luria D, Gurevitz O, Bar-Lev D, Eldar M, Glikson M.
    Europace; 2014 Feb 01; 16(2):227-34. PubMed ID: 24108231
    [Abstract] [Full Text] [Related]

  • 13. Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants.
    Rowin EJ, Burrows A, Madias C, Estes NAM, Link MS, Maron MS, Maron BJ.
    Circ Arrhythm Electrophysiol; 2020 Oct 01; 13(10):e008123. PubMed ID: 32897759
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy test of defibrillation in patients with cardiac resynchronization therapy with defibrillator CRT-D].
    Lubiński A.
    Kardiol Pol; 2010 May 01; 68(5):519. PubMed ID: 20491011
    [No Abstract] [Full Text] [Related]

  • 15. Subcutaneous Implantable Cardioverter Defibrillator: Early Experience.
    Souza FSO, Matos VS, Almeida MCV, Weiss SC, Rodrigues LHB, Lima PAG, Mattos DB.
    Braz J Cardiovasc Surg; 2017 May 01; 32(6):498-502. PubMed ID: 29267613
    [Abstract] [Full Text] [Related]

  • 16. Relationship of Shock Energy to Impedance During Subcutaneous Implantable Cardioverter-Defibrillator Testing.
    Payne JE, Badertscher P, Field ME, Sturdivant JL, Gold MR.
    Circ Arrhythm Electrophysiol; 2020 Sep 01; 13(9):e008631. PubMed ID: 32703008
    [No Abstract] [Full Text] [Related]

  • 17. Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-end.
    Noel A, Ploux S, Bulliard S, Strik M, Haeberlin A, Welte N, Marchand H, Klotz N, Ritter P, Haïssaguerre M, Bordachar P.
    Heart Rhythm; 2020 Jan 01; 17(1):66-74. PubMed ID: 31295585
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.
    Maurizi N, Olivotto I, Olde Nordkamp LR, Baldini K, Fumagalli C, Brouwer TF, Knops RE, Cecchi F.
    Heart Rhythm; 2016 Feb 01; 13(2):457-63. PubMed ID: 26362577
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA.
    Europace; 2013 Mar 01; 15(3):347-54. PubMed ID: 23002195
    [Abstract] [Full Text] [Related]

  • 20. Seventh try's a charm: ventricular fibrillation terminated by the seventh shock.
    Li J, Zitron E, Katus HA, Becker R.
    Circ Arrhythm Electrophysiol; 2011 Apr 01; 4(2):e4-6. PubMed ID: 21505170
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.